| Execution period | 5 years |
|---|
BSE filing, NSE: INDOUS. Summary written from the filing by ALFA Finder's alert engine.
Indo US Bio-Tech Ltd: key numbers
- Share price
- ₹86.84
- Market cap
- ₹174.1 Cr
- Revenue (annual)
- ₹110.4 Cr
- Net profit (annual)
- ₹13.12 Cr
- P/E (TTM)
- 15.2×Sector 26.2×
- Promoter holding
- 68.29%+0.00% QoQ
- FII holding
- 0.01%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Indo US Bio-Tech Ltd
All →Indo US Bio-Tech Board Meeting Date
Indo Us Bio-Tech has intimated that its board will meet on 30 October 2026 to consider unaudited standalone results for the quarter and half year ended 30 September 2026. The notice is advance intimation only, with no results yet reported.
Indo US Bio-Tech Business Update
Indo Us Bio-Tech disclosed promoter invitations to attend China's 140th Canton Fair. The filing states no financial value or business commitment.
Indo US Bio-Tech Other Announcement
Indo Us Bio-Tech Ltd filed its quarterly shareholding pattern under SEBI Regulation 31(1)(b) for the quarter ended September 30, 2026.
Indo US Bio-Tech Annual General Meeting
Indo Us Bio-Tech Limited held its 22nd Annual General Meeting on September 30, 2026. The filing provides a gist of the meeting's proceedings and agenda items.
Indo US Bio-Tech Annual Report
Indo Us Bio-Tech Ltd submitted its Annual Report for FY 2025-2026. The 22nd Annual General Meeting is scheduled for September 30, 2026.
Indo US Bio-Tech Annual General Meeting
Indo Us Bio-Tech Limited has issued a notice for its 22nd Annual General Meeting, scheduled for September 30, 2026, to be conducted via video conferencing.
Other management change announcements
All →Hexaware Technologies Management Change
Hexaware appointed Arjun Shah and Gregory Zeluck as Non-Executive Directors from 28 October 2026. Directors Neeraj Bharadwaj and Julius Genachowski resigned, and Girish Pai's resignation is effective 13 November 2026.
GMR Airports Management Change
GMR Airports appointed Sanjeev Gupta as Executive Director (Deputy CEO) effective 29 October 2026. Non-Executive Director Alexis Riols resigned effective 28 October 2026.
Raymond Realty Management Change
Raymond Realty said joint statutory auditor Chaturvedi & Shah LLP resigned on 28 October 2026 after a dispute over audit fee revision. Walker Chandiok & Co LLP continues as the other statutory auditor.
Aarti Pharmalabs Management Change
Aarti Pharmalabs accepted CFO Piyush Lakhani's resignation, effective 30 October 2026, and appointed Vibha Thakker as CFO from 31 October 2026. The filing records a senior management change with no monetary amount.
TruCap Finance Management Change
TruCap Finance designated three employees as Senior Management Personnel, effective 29 October 2026. The changes are additional charges for Product, Operations and Contact Centre roles.
Sayaji Hotels (Indore) Management Change
Sayaji Hotels (Indore) appointed Azhar Yusuf Dhanani as Additional Non-Executive Non-Independent Director effective October 28, 2026. Shareholder approval is required within three months.